McHenry, IL, May 05, 2022 (GLOBE NEWSWIRE) -- Medela, the most trusted breast pump brand*, has announced a partnership with Expectful, a holistic maternal health platform for fertility, pregnancy, and ...
Message from the CEO IBT's vision is to become an internationally leading company in the development of pharmaceuticals in the areas of premature infants, gastrointestinal diseases and probiotics. We have ...
Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Wednesday, May 4, 2022. In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant ...
Press release March 31, 2022 Infant Bacterial Therapeutics AB (publ) publishes today the Annual Report for 2021. The report is available on IBT’s website ibtherapeutics.com under the section “Investors & ...
Press release February 4, 2022 Message from the CEO IBT’s ongoing pivotal phase lll clinical trial aims to generate data to improve survival possibilities of premature infants. This is accomplished ...
Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong have approved a patent of Lactobacillus reuteri covering IBP-9414. IBT is currently developing its drug ...
New Jersey, United Kingdom, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Infant Formula Ingredients Market By Ingredient Type, By Source, By ...
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021 Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), ...
Stockholm, October 29, 2021. The Chairman of IBT has established a Nomination Committee for the AGM, which is planned to be held on May 4, 2022. The Nomination Committee is composed, ...
Copyright © 2015 - 2021 Lifecarenews.in
